Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Wall Street Analysts Believe Insmed (INSM) Could Rally 98.26%: Here's is How to Trade
11:17am, Tuesday, 24'th Jan 2023
The mean of analysts' price targets for Insmed (INSM) points to a 98.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Insmed To Present at the Nasdaq 47th Investor Conference
08:00am, Wednesday, 30'th Nov 2022
BRIDGEWATER, N.J. , Nov. 30, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Insmed Incorporated (INSM) Q3 2022 Earnings Call Transcript
01:38pm, Thursday, 27'th Oct 2022
Insmed Incorporated (NASDAQ:INSM ) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Will Lewis - Chair & CEO Sara Bonstein - CFO Eleanor Barisser - IR Conference Call
Why Insmed's Shares Fell 14.7% on Wednesday
05:14pm, Wednesday, 19'th Oct 2022
The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process.
Insmed (INSM) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Tuesday, 04'th Oct 2022
Insmed (INSM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Insmed Incorporated (INSM) CEO Will Lewis on Q2 2022 Results - Earnings Call Transcript
05:54pm, Friday, 05'th Aug 2022
Insmed Incorporated (NASDAQ:INSM ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Eleanor Barisser - Investor Relations Will Lewis - Chair & Chief Executive Officer Sa
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
11:18am, Thursday, 04'th Aug 2022
Insmed (INSM) delivered earnings and revenue surprises of 10.11% and 11.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Insmed Inc. (INSM) CEO Will Lewis on Q1 2022 Results - Earnings Call Transcript
02:33pm, Saturday, 07'th May 2022
Insmed Inc. (NASDAQ:INSM ) Q1 2022 Results Conference Call May 5, 2022 8:30 AM ET Company Participants Eleanor Barisser - IR Will Lewis - Chairman, CEO Sara Bonstein - CFO Conference Call Participants
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates
01:05pm, Thursday, 05'th May 2022 Zacks Investment Research
Insmed (INSM) delivered earnings and revenue surprises of 12.09% and 0.98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
07:02pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022
02:02pm, Wednesday, 27'th Apr 2022 Benzinga
Upgrades
BTIG upgraded the previous rating for Acutus Medical Inc (NASDAQ:AFIB) from Neutral to Buy. In the fourth quarter, Acutus Medical showed an EPS of $1.00, compared to $0.89 from the year-ago
Insmed Incorporated 2022 Q4 - Results - Earnings Call Presentation
04:41pm, Thursday, 17'th Feb 2022 Seeking AlphaInsmed Incorporated's (INSM) CEO Will Lewis on Q4 2021 Results - Earnings Call Transcript
02:02pm, Thursday, 17'th Feb 2022
Insmed Incorporated's (INSM) CEO Will Lewis on Q4 2021 Results - Earnings Call Transcript
Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates
01:25pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Insmed (INSM) delivered earnings and revenue surprises of -6.74% and 10.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
